ÂÜÀòÂÒÂ×

David Joseph Ballard is currently serving as the Chief Clinical Officer at Buffkin / Baker, and is an active member on various Board of Directors and advisory boards for companies such as Sniffle, Concentric Health Alliance, Courage Ventures Funds, Ataia Medical, Mentice, Pascal Metrics, InSyncDx Solutions, and as an Adjunct Professor at the University of North Carolina at Chapel Hill. With an extensive educational background in various fields including Chemistry, Economics, Epidemiology, Medicine, and Business, David brings a wealth of knowledge and expertise to the healthcare industry.